The BCL2 antagonist ABT‐199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4Wild‐type and CXCR4WHIM mutated Waldenstrom macroglobulinaemia cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|170|1|134-138

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.1, 2015-07, pp. : 134-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CXCR4 WHIM‐like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P‐directed survival signalling in Waldenström macroglobulinaemia cells

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 701-707

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination of ibrutinib with ABT‐199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 765-768

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dysregulation of circulating CD4+CXCR5+ T cells in type 2 diabetes mellitus

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 2, 2015-02 ,pp. : 146-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYD88 wild‐type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 374-380

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anomalies de l’axe de signalisation CXCL12 (SDF-1)/CXCR4 dans le syndrome WHIM et la lymphopénie T CD4+ idiopathique

By Biajoux Vincent   Bignon Alexandre   Bouchet-Delbos Laurence   Émilie Dominique   Balabanian Karl  

Biologie Aujourd'hui, Vol. 204, Iss. 4, 2011-01 ,pp. : 273-284

Edp Sciences

Access to resources Recommend Favorite